Carpio, D <br/><br/>
Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment.  [electronic resource] 

 -  Journal of Crohn's & colitis  Oct 2016 
 - 1186-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study 
<br/><br/><label>ISSN: </label>1876-4479 
<br/><br/><label>Standard No.: </label>10.1093/ecco-jcc/jjw022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--therapeutic use<br/>Adult<br/>Female<br/>Follow-Up Studies<br/>Guideline Adherence--statistics & numerical data<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Inflammatory Bowel Diseases--complications<br/>Infliximab--therapeutic use<br/>Male<br/>Middle Aged<br/>Opportunistic Infections--complications<br/>Practice Guidelines as Topic<br/>Retreatment<br/>Retrospective Studies<br/>Spain<br/>Treatment Outcome<br/>Tuberculin Test--statistics & numerical data<br/>Tuberculosis--complications